Doctor profile · Federal record
Dr. Dale Kooistra, M.D., PHD.
Dermatology Physician (CMS: Dermatology) · Poway, CA
- NPI 1831182971
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 42 yrs in practice
- Male
- No sanctions
Practice & contact
- Primary practice
-
15525 Pomerado RD, Suite D2
Poway, CA 920642435
(858) 675-8001
fax (858) 487-1337
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #G55734
- Medicaid
- CA #00G557340
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831182971. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,984
Distinct HCPCS
10
Medicare allowed
$130,992
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 870 | 141 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 295 | 203 | $97 | |
17000 |
Destruction of precancer skin growth, 1 growth | 244 | 175 | $64 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 175 | 139 | $137 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 65 | 17 | $1 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 64 | 46 | $189 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 61 | 49 | $61 | |
17110 |
Destruction of skin growth, 1-14 growths | 55 | 51 | $128 | |
11102 |
Biopsy of related skin growth, first growth | 47 | 45 | $111 | |
17311 |
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 23 | 22 | $640 |
In context: peer comparison
Among 2 peers in Poway Dermatology Physician, average services per provider: 108. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$1,022
Transactions
51
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $323.35 | |
| Janssen Biotech, INC. | 15 | $253.16 | |
| Regeneron Healthcare Solutions, INC. | 4 | $100.32 | |
| Novartis Pharmaceuticals Corporation | 4 | $93.05 | |
| Pfizer INC. | 3 | $74.42 | |
| Incyte Corporation | 2 | $29.30 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $28.05 | |
| Leo Pharma INC. | 1 | $25.75 | |
| Ucb, INC. | 1 | $25.19 | |
| Revance Therapeutics, INC. | 1 | $20.99 | |
| Tempus Ai, INC | 1 | $18.18 | |
| Biofrontera INC. | 2 | $16.70 | |
| Abbvie INC. | 1 | $13.71 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
575
Patients
345
Total drug cost
$96,940
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Cefadroxil | Generic | 150 | 136 | $1,400 |
| Triamcinolone Acetonide | Generic | 83 | 52 | $500 |
| Clobetasol Propionate | Generic | 67 | 47 | $3,657 |
| Terbinafine Hcl | Generic | 52 | 18 | $185 |
| Doxycycline Hyclate | Generic | 42 | 15 | $1,915 |
| Fluticasone Propionate | Generic | 32 | 20 | $1,101 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 31 | 23 | $836 |
| Methotrexate (Methotrexate Sodium) | Brand | 24 | 0 | $558 |
| Fluorouracil | Generic | 23 | 21 | $2,420 |
| Fluconazole | Generic | 19 | 0 | $108 |
Frequently asked questions
What is Dr. Dale Kooistra's medical specialty?
Dr. Dale Kooistra practices Dermatology Physician in Poway, CA.
Where does Dr. Dale Kooistra practice?
Dr. Dale Kooistra practices at 15525 Pomerado RD, Poway, CA 920642435. Office phone: 8586758001.
What is Dr. Dale Kooistra's NPI?
Dr. Dale Kooistra's National Provider Identifier (NPI) is 1831182971, issued by NPPES.
Does Dr. Dale Kooistra accept Medicare assignment?
Yes. Dr. Dale Kooistra accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dale Kooistra commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.